| Date: | 06/05/2026 |
|---|---|
| Organization: | Department of Public Health |
| Regulatory Authority: | MGL c. 111, §§ 3, 4E, 5, 6, 24A, 110A |
| Official Version: | Purchase the official print version |
105 CMR 270.000 lists mandated screening tests for diseases and disorders with treatments that are known to be more effective if the condition is identified in the newborn period and for which there is a reliable and effective blood screening test that may be administered during the newborn period, and that there is a diagnostic protocol.
Download a PDF copy of the regulation below.